U.S. Markets
Boston Scientific (BSX) says that the cybersecurity incident is likely to materially affect Q3 and FY26 results; says it is unlikely to meet prior net sales growth and Adj. EPS guidance
StockNow breaking-news AI analysis
Boston Scientific warned that its August cybersecurity incident will materially hit Q3 and FY26 results, impairing prior sales and EPS guidance despite ongoing manufacturing and distribution recovery.
Related stocks
1 stocksWhat do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
